ATPW
HAE icon

Ashton Thomas Private Wealth’s Haemonetics HAE Stock Holding History

Ashton Thomas Private Wealth’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,631
Closed -$284K – 813
2024
Q4 		$284K Buy
+3,631
New +$292K 0.01% 648
2024
Q3 		– Sell
-1,686
Closed -$139K – 1129
2024
Q2 		$139K Sell
1,686
-1,152
-41% -$101K 0.01% 671
2024
Q1 		$242K Buy
+2,838
New +$223K 0.01% 533

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ashton Thomas Private Wealth's HAE Position: Q1 2025 in Review

Ashton Thomas Private Wealth sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 3,631 shares — an estimated $284K sold.

Ashton Thomas Private Wealth first reported a position in HAE in Q1 2024 and held it in 3 quarters. The position peaked at $284K in Q4 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Ashton Thomas Private Wealth reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 3,631 Haemonetics shares in Q1 2025, an estimated $284K.
  • Ashton Thomas Private Wealth first reported a position in Haemonetics in Q1 2024 and held it in 3 quarters.
  • Ashton Thomas Private Wealth's Haemonetics position peaked at $284K in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2025, filed 16 May 2025.